183 related articles for article (PubMed ID: 22982547)
1. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.
Miller BJ; Mellor A; Buckley P
Brain Behav Immun; 2013 Jul; 31():82-9. PubMed ID: 22982547
[TBL] [Abstract][Full Text] [Related]
2. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.
Miller BJ; Kandhal P; Rapaport MH; Mellor A; Buckley P
Brain Behav Immun; 2015 Mar; 45():28-35. PubMed ID: 25542737
[TBL] [Abstract][Full Text] [Related]
3. Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
Mori N; McEvoy JP; Miller BJ
Schizophr Res; 2015 Dec; 169(1-3):30-35. PubMed ID: 26475215
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome, Total and Differential White Blood Cell Counts in Patients with Schizophrenia.
Pavlović M; Babić D; Rastović P; Babić R; Vasilj M
Psychiatr Danub; 2016 Dec; 28 Suppl 2():216-222. PubMed ID: 28035126
[TBL] [Abstract][Full Text] [Related]
5. Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
Kelly CW; McEvoy JP; Miller BJ
Schizophr Res; 2019 Jul; 209():193-197. PubMed ID: 31118157
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.
Correll CU; Robinson DG; Schooler NR; Brunette MF; Mueser KT; Rosenheck RA; Marcy P; Addington J; Estroff SE; Robinson J; Penn DL; Azrin S; Goldstein A; Severe J; Heinssen R; Kane JM
JAMA Psychiatry; 2014 Dec; 71(12):1350-63. PubMed ID: 25321337
[TBL] [Abstract][Full Text] [Related]
7. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.
Fan X; Liu EY; Freudenreich O; Park JH; Liu D; Wang J; Yi Z; Goff D; Henderson DC
Schizophr Res; 2010 May; 118(1-3):211-7. PubMed ID: 20189773
[TBL] [Abstract][Full Text] [Related]
8. Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis.
Moody G; Miller BJ
Psychiatry Res; 2018 Feb; 260():307-312. PubMed ID: 29223800
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of total and differential white blood cell counts in schizophrenia.
Jackson AJ; Miller BJ
Acta Psychiatr Scand; 2020 Jul; 142(1):18-26. PubMed ID: 31850530
[TBL] [Abstract][Full Text] [Related]
10. Association of leukocyte count and hsCRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES - 64).
Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
J Assoc Physicians India; 2009 Jan; 57():27-32. PubMed ID: 19753755
[TBL] [Abstract][Full Text] [Related]
11. Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia.
Pan S; Tan Y; Yao S; Zhao X; Xiong J
Psychiatry Res; 2016 Dec; 246():89-94. PubMed ID: 27669496
[TBL] [Abstract][Full Text] [Related]
12. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
[TBL] [Abstract][Full Text] [Related]
13. Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia.
Goetz RL; Miller BJ
J Nerv Ment Dis; 2019 Aug; 207(8):633-636. PubMed ID: 31232907
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study.
Russell A; Ciufolini S; Gardner-Sood P; Bonaccorso S; Gaughran F; Dazzan P; Pariante CM; Mondelli V
Brain Behav Immun; 2015 Oct; 49():25-9. PubMed ID: 26100489
[TBL] [Abstract][Full Text] [Related]
15. Effect of Ramadan fasting on anthropometric, metabolic, inflammatory and psychopathology status of Egyptian male patients with schizophrenia.
Fawzi MH; Fawzi MM; Said NS; Fawzi MM; Fouad AA; Abdel-Moety H
Psychiatry Res; 2015 Feb; 225(3):501-8. PubMed ID: 25529262
[TBL] [Abstract][Full Text] [Related]
16. Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders.
Scheffler F; Kilian S; Chiliza B; Asmal L; Phahladira L; du Plessis S; Kidd M; Murray RM; Di Forti M; Seedat S; Emsley R
Schizophr Res; 2018 Sep; 199():90-95. PubMed ID: 29519756
[TBL] [Abstract][Full Text] [Related]
17. General Lack of Correlations between Age and Signs of the Metabolic Syndrome in Subjects with Non-diabetic Fasting Glucose Values.
Preuss HG; Mrvichin N; Clouatre D; Bagchi D; Preuss JM; Perricone NV; Swaroop A; Kaats GR
J Am Coll Nutr; 2017; 36(7):556-564. PubMed ID: 28895791
[TBL] [Abstract][Full Text] [Related]
18. ASSOCIATION OF PERIPHERAL 5-HYDROXYINDOLE-3-ACETIC ACID, A SEROTONIN DERIVATIVE, WITH METABOLIC SYNDROME AND LOW-GRADE INFLAMMATION.
Afarideh M; Behdadnia A; Noshad S; Mirmiranpour H; Mousavizadeh M; Khajeh E; Rad MV; Mazaheri T; Nakhjavani M; Esteghamati A
Endocr Pract; 2015 Jul; 21(7):711-8. PubMed ID: 25716631
[TBL] [Abstract][Full Text] [Related]
19. Blood cell count in antipsychotic-naive patients with non-affective psychosis.
Garcia-Rizo C; Casanovas M; Fernandez-Egea E; Oliveira C; Meseguer A; Cabrera B; Mezquida G; Bioque M; Kirkpatrick B; Bernardo M
Early Interv Psychiatry; 2019 Feb; 13(1):95-100. PubMed ID: 28786532
[TBL] [Abstract][Full Text] [Related]
20. The regulation of serum resistin levels in metabolically healthy and unhealthy obese individuals.
Christou KA; Christou GA; Karamoutsios A; Vartholomatos G; Gartzonika K; Tsatsoulis A; Tigas S
Hormones (Athens); 2020 Dec; 19(4):523-529. PubMed ID: 32328905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]